Subject(s)

Autoimmune Diseases , COVID-19 , Hydroxymethylglutaryl-CoA Reductase Inhibitors , Motor Neuron Disease , Muscular Diseases , Myositis , Autoantibodies , Diagnostic Errors , Humans , Motor Neuron Disease/complications , Motor Neuron Disease/diagnosis , Muscular Diseases/complications , Muscular Diseases/diagnosis , SARS-CoV-2